The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy
Open accessAbstract
Spinal muscular atrophy (SMA) is a neuromuscular disease caused by a deficiency of survival motor neuron (SMN) due to mutations in the SMN1 gene. In this study, an adeno-associated virus (AAV) vector expressing human SMN (AAV8-hSMN) was injected at birth into the CNS of mice modeling SMA. Western blot analysis showed that these injections resulted in widespread expression of SMN throughout the spinal cord, and this translated into robust improvement in skeletal muscle physiology, including increased myofiber size and improved neuromuscular junction architecture. Treated mice also displayed substantial improvements on behavioral tests of muscle strength, coordination, and locomotion, indicating that the neuromuscular junction was functional. Treatment with AAV8-hSMN increased the median life span of mice with SMA-like disease to 50 days compared with 15 days for untreated controls. Moreover, injecting mice with SMA-like disease with a human SMN-expressing self-complementary AAV vector - a vector that leads to earlier onset of gene expression compared with standard AAV vectors - led to improved efficacy of gene therapy, including a substantial extension in median survival to 157 days. These data indicate that CNS-directed, AAV-mediated SMN augmentation is highly efficacious in addressing both neuronal and muscular pathologies in a severe mouse model of SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Correlation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
Wang, C. H., Finkel, R. S., Bertini, E. S., Schroth, M., Simonds, A., Wong, B., Aloysius, A., Morrison, L., Main, M., Crawford, T. O., et al. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305788 · Cited by 961
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Burghes, A. H. M., & Beattie, C. E. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2670 · Cited by 723
Rossoll, W., Jablonka, S., Andreassi, C., Kröning, A.-K., Karle, K., Monani, U. R., & Sendtner, M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304128 · Cited by 638
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Hua, Y., Vickers, T. A., Okunola, H. L., Bennett, C. F., & Krainer, A. R. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.014 · Cited by 574
Self-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
Duque, S., Joussemet, B., Riviere, C., Marais, T., Dubreil, L., Douar, A.-M., Fyfe, J., Moullier, P., Colle, M.-A., & Barkats, M. (2009) · Molecular Therapy · doi:10.1038/mt.2009.71 · Cited by 511
Singh, N. K., Singh, N. N., Androphy, E. J., & Singh, R. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1333-1346.2006 · Cited by 454
Kariya, S., Park, G.-H., Maeno-Hikichi, Y., Leykekhman, O., Lutz, C., Arkovitz, M. S., Landmesser, L. T., & Monani, U. R. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn156 · Cited by 445
Treatment of spinal muscular atrophy by sodium butyrate
Chang, J.-G., Hsieh-Li, H.-M., Jong, Y.-J., Wang, N. M., Tsai, C.-H., & Li, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171105098 · Cited by 404
Murray, L. M., Comley, L. H., Thomson, D., Parkinson, N., Talbot, K., & Gillingwater, T. H. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm367 · Cited by 387
Brichta, L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg256 · Cited by 382
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Avila, A. M., Burnett, B. G., Taye, A. A., Gabanella, F., Knight, M. A., Hartenstein, P., Cizman, Z., Di Prospero, N. A., Pellizzoni, L., Fischbeck, K. H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29562 · Cited by 350
Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon
Hua, Y., Vickers, T. A., Baker, B. F., Bennett, C. F., & Krainer, A. R. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050073 · Cited by 340
Campbell, L., Potter, A., Ignatius, J., Dubowitz, V., & Davies, K. (1997) · The American Journal of Human Genetics · doi:10.1086/513886 · Cited by 325
Gabanella, F., Butchbach, M. E. R., Saieva, L., Carissimi, C., Burghes, A. H. M., & Pellizzoni, L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000921 · Cited by 315
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
Sumner, C. J., Huynh, T. N., Markowitz, J. A., Perhac, J. S., Hill, B., Coovert, D. D., Schussler, K., Chen, X., Jarecki, J., Burghes, A. H. M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10743 · Cited by 289
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
Andreassi, C., Angelozzi, C., Tiziano, F. D., Vitali, T., De Vincenzi, E., Boninsegna, A., Villanova, M., Bertini, E., Pini, A., Neri, G., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201102 · Cited by 255
Cifuentes-Diaz, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1439 · Cited by 254
Andreassi, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2841 · Cited by 229
Gavrilina, T. O., McGovern, V. L., Workman, E., Crawford, T. O., Gogliotti, R. G., DiDonato, C. J., Monani, U. R., Morris, G. E., & Burghes, A. H. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm379 · Cited by 212
Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy
Azzouz, M., Le, T., Ralph, G. S., Walmsley, L., Monani, U. R., Lee, D. C. P., Wilkes, F., Mitrophanous, K. A., Kingsman, S. M., Burghes, A. H. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422922 · Cited by 209
Congenital heart disease is a feature of severe infantile spinal muscular atrophy
Rudnik-Schöneborn, S., Heller, R., Berg, C., Betzler, C., Grimm, T., Eggermann, T., Eggermann, K., Wirth, R., Wirth, B., & Zerres, K. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.057950 · Cited by 202
Passini, M. A., & Wolfe, J. H. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12382-12392.2001 · Cited by 185
Self-citationSustained improvement of spinal muscular atrophy mice treated with trichostatin a plus nutrition
Narver, H. L., Kong, L., Burnett, B. G., Choe, D. W., Bosch‐Marcé, M., Taye, A. A., Eckhaus, M., & Sumner, C. J. (2008) · Annals of Neurology · doi:10.1002/ana.21449 · Cited by 160
Hahnen, E., Eyüpoglu, I. Y., Brichta, L., Haastert‐Talini, K., Tränkle, C., Siebzehnrübl, F. A., Rießland, M., Hölker, I., Claus, P., Romstöck, J., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03868.x · Cited by 157
Corti, S. P., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Ronchi, D., Saladino, F., Bordoni, A., Fortunato, F., Bo, R. D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35432 · Cited by 142
Ml, Z., Lorson, C., Androphy, E. J., & Zhou, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301550 · Cited by 140
Rießland, M., Brichta, L., Hahnen, E., & Wirth, B. (2006) · Human Genetics · doi:10.1007/s00439-006-0186-1 · Cited by 126
Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells
Grzeschik, S. M., Ganta, M., Prior, T. W., Heavlin, W. D., & Wang, C. H. (2005) · Annals of Neurology · doi:10.1002/ana.20548 · Cited by 113
Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
Butchbach, M. E. R., Edwards, J. D., & Burghes, A. H. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.009 · Cited by 112
Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy
Lesbordes, J.-C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg143 · Cited by 107
Modern Management of Spinal Muscular Atrophy
Iannaccone, S. T. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305670 · Cited by 101
El‐Khodor, B. F., Edgar, N. M., Chen, A., Winberg, M. L., Joyce, C. L., Brunner, D., Suárez‐Fariñas, M., & Heyes, M. P. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.02.025 · Cited by 101
Therapeutics development for spinal muscular atrophy
Sumner, C. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.010 · Cited by 97
Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells
Angelozzi, C., Borgo, F., Tiziano, F. D., Martella, A., Neri, G., & Brahe, C. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051177 · Cited by 91
Restoration of SMN Function: Delivery of a Trans-splicing RNA Re-directs SMN2 Pre-mRNA Splicing
Coady, T. H., Shababi, M., Tullis, G. E., & Lorson, C. L. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300222 · Cited by 90
Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts
Coady, T. H., Baughan, T. D., Shababi, M., Passini, M. A., & Lorson, C. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003468 · Cited by 85
Self-citationOskoui, M., & Kaufmann, P. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.007 · Cited by 69
Induction of full-length survival motor neuron by polyphenol botanical compounds
Sakla, M. S., & Lorson, C. L. (2007) · Human Genetics · doi:10.1007/s00439-007-0441-0 · Cited by 63
Animal Models of Spinal Muscular Atrophy
Schmid, A., & DiDonato, C. J. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305667 · Cited by 57
Interferons and IRF-1 Induce Expression of the Survival Motor Neuron (SMN) Genes
Baron-Delage, S., Abadie, A., Echaniz‐Laguna, A., Melki, J., & Beretta, L. (2000) · Molecular Medicine · doi:10.1007/bf03401830 · Cited by 55
Husain, T., Passini, M. A., Parente, M. K., Fraser, N., & Wolfe, J. H. N. (2009) · Gene Therapy · doi:10.1038/gt.2009.52 · Cited by 39
Self-citationYuo, C., Lin, H., Chang, Y., Yang, W., & Chang, J. (2007) · Annals of Neurology · doi:10.1002/ana.21241 · Cited by 37
Cited by
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 664
Self-citationKolb, S. J., & Kissel, J. T. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.004 · Cited by 603
D'Amico, A., Mercuri, E., Tiziano, F. D., & Bertini, E. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-71 · Cited by 577
Passini, M. A., Bu, J., Richards, A. M., Kinnecom, C., Sardi, S. P., Stanek, L. M., Hua, Y., Rigo, F., Matson, J., Hung, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001777 · Cited by 547
Self-citation
Metadata
- Authors
- Passini, M. A., Bu, J., Roskelley, E. M., Richards, A. M., Sardi, S. P., O’Riordan, C. R., Klinger, K. W., Shihabuddin, L. S., & Cheng, S. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-04-01
- Volume
- 120
- Issue
- 4
- Pages
- 1253-1264
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2088820444
- Cited by
- 292
- References
- 50
- FWCI
- 15.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.